Real-world stroke prevention strategies in nonvalvular atrial fibrillation in patients with renal impairment.
Kadir Uğur MertGurbet Ö MertÖzcan BaşaranOsman BetonVolkan DoganMehmet TekinalpAhmet Ç AykanEzgi KalaycıoğluIsmail BolatOnur TaşarÖzgen ŞafakMacit KalçıkMehmet YamanCevat KırmaMurat Bitekernull nullPublished in: European journal of clinical investigation (2017)
RAMSES study showed that one-third of the patients with NVAF had RI in the real-world setting. Although it is mandatory in most of the patients with concomitant NVAF and RI, nearly one-third of these patients did not receive any anticoagulant therapy.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- end stage renal disease
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- left atrial
- newly diagnosed
- ejection fraction
- chronic kidney disease
- venous thromboembolism
- percutaneous coronary intervention
- peritoneal dialysis
- stem cells
- patient reported outcomes
- left ventricular
- blood brain barrier
- cell therapy
- replacement therapy
- smoking cessation